Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenichi Ogiwara
Factor (F)viii/VIIa Enhances Global Haemostatic Function in the Co-Presence of Bypassing Agents and FVIII Among Patients With Haemophilia a With Inhibitor
British Journal of Haematology
Hematology
Related publications
Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII
BMJ
Recombinant Factor VIIa for the Prevention and Treatment of Bleeding in Patients Without Haemophilia
Long-Term Treatment Course of a Patient With Mild Haemophilia a Who Developed a High Titre Factor VIII Inhibitor
Haemophilia
Medicine
Genetics
Hematology
Management of Coagulation Factor VIII (FVIII) Inhibitors
Thrombosis Research
Hematology
The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors
Oncology & Hematology Review (US)
Immune Status of Patients With Haemophilia a Before Exposure to Factor VIII: First Results From the HEMFIL Study
British Journal of Haematology
Hematology
Citrate Artificially Masks the Haemostatic Effect of Recombinant Factor VIIa in Dilutional Coagulopathy
Annals of Hematology
Medicine
Hematology
Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science
Psy139 - Current Use of Factor Viii Products in Children and Adolescents With Moderate or Severe Haemophilia A
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
